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Summary
Objectives: To study the evolution of antibiotic resistance in isolates of Salmonella enterica
subspecies enterica serovar Typhimurium (Salmonella Typhimurium) obtained in Uruguay between
the years 1976 and 2000, and to determine the incidence of class 1 and 2 integrons in the multi-
resistant isolates.
Methods: We studied 258 strains of Salmonella Typhimurium from various sources, isolated
between 1976 and 2000. We determined the evolution of antibiotic resistance and the distribution
of class 1 and 2 integrons in all isolates by means of disk diffusion assays and PCR.
Results: During the period 1989—2000 resistance to streptomycin was 56.8%, tetracycline 13.6%,
sulfonamides 11.2%, and ampicillin 7.2%. Resistance to gentamicin, kanamycin, chloramphenicol,
and nalidixic acid were lower than 5%; no resistance was detected to fluoroquinolones, oxyimi-
nocephalosporins, and amikacin. These results show a dramatic decrease with respect to values
found in the period 1976—1988. In this period, resistance to streptomycin was 63.2%, tetracycline
36.8%, sulfonamides 32.3%, and ampicillin 27.8%. Throughout the two periods, 29 multi-resistant
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Salmonella Typhimurium strains were isolated harboring some class of integron: 15 strains had only
intI2, 11 strains presented both intI1 and intI2, and three isolates only intI1.
Conclusions: Our results show a marked decrease in resistance throughout these years, along with a
correlation between resistance to different antibiotics and the presence of integrons.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Salmonella enterica subspecies enterica serovar Typhimur-
ium (Salmonella Typhimurium) is an important food-borne
pathogen in humans and a broad range of animals. The
spectrum of disease in humans comprises gastrointestinal
infections and extra-intestinal infections such as bacteremia,
central nervous system infections, and bone and urinary tract
infections, among others.
In Uruguay, Salmonella Typhimurium has been one of the
main causes of human salmonellosis since 1971,1,2 second
only to Salmonella Enteritidis since 1995.3 This epidemiolo-
gical situation is similar to other countries in Latin America
and the rest of the world.4—6
Taking into consideration that most Salmonella infections
consist of mild and self-limited gastrointestinal episodes,
antibiotic treatment is administered only in cases of severe
infection that may occur in patients such as young children,
the elderly, and the immunocompromised.
Antibiotic resistance in Salmonella Typhimurium is a re-
emerging problem worldwide. In our country, multi-resistant
isolates (defined as those having resistance to four or more
classes of antibiotics)7 have been reported since 1975;8
different enteric pathogens, such as other Salmonella ser-
ovars and enteropathogenic Escherichia coli (EPEC), have
also been highlighted as important reservoirs of resistance
genes.9,10 Antibiotic administration generates selective pres-
sure over bacterial species capable of incorporating new
genetic material that may confer resistance to such drugs.
In this context integrons play an important role in the capture
and expression of exogenous genetic material. So far, nine
classes of integrons have been described, with those of class
1 and 2 being most frequently associated with resistance in
clinical isolates.11,12
Briefly, integrons are classified according to the integrase
gene (intI) nucleotide sequence. In class 1 integrons, the
intI1 gene together with Pant (integrase promoter), Pc (gene
cassette promoter), and attI (integrase recognition site)
constitute the 50 conserved segment (50CS). The 30 conserved
segment (30CS) is basically formed of a truncated copy of
qacED1, which confers resistance to quaternary ammonium
compounds, and the sul1 gene, which codes for sulfonamide
resistance. Between these two conserved segments lies the
variable region (VR), containing different arrangements of
gene cassettes. These gene cassettes lack a promoter of their
own, however they are associated with a 59-bp element (59-
be) or attC, the recognition site for the integrase. With this
structure, class 1 integrons are able to incorporate and
express gene cassettes that generally code for antibiotic
resistance.11
Class 2 integrons have a similar structure to the integrons
mentioned above; the 50CS is constituted of the intI2 gene,
the 30CS is formed of five tns genes responsible for transposi-
tion, and, finally, a VR is located between both conservedsegments. However, intI2 presents a stop codon at amino acid
position 179, which prevents IntI2 from integrating or excis-
ing new gene cassettes.13 Because of this, while more than 60
antibiotic resistance genes have been found associated with
class 1 integrons,11 class 2 integron-associated antibiotic
resistance genes number scarcely more than a dozen. Among
others, these stand out: streptothricin acetyltransferase
(sat2), type I dihydrofolate reductase (dfrA1), and strepto-
mycin 30-adenyltransferase (aadA1). Recently, other genes
have been characterized: chloramphenicol acetyltransferase
(catB2),14 erythromycin esterase (ereA),15 and dihydroptero-
ate synthase (sul1 or dhps).16
Due to the fact that these genetic elements may be
horizontally disseminated and that Salmonella antibiotic
susceptibility does not have a homogeneous distribution
(neither geographical nor temporal), surveillance programs
must be undertaken to monitor the evolution of antibiotic
resistance and the presence of mobile genetic elements.
In this work, we report the results of a study on the
evolution of antibiotic resistance in human isolates of Sal-
monella Typhimurium received at the Centro Nacional de
Salmonella (CNS) in Uruguay between the years 1976 and
2000; we also determined the presence of class 1 and 2
integrons in the multi-resistant isolates.
Materials and methods
Bacterial strains
All Salmonella Typhimurium strains of human origin
received at the CNS between the years 1976 and 2000 were
selected for the present study. The CNS is housed in the
Departamento de Bacteriologı´a y Virologı´a, Instituto de
Higiene, Universidad de la Repu´blica, Montevideo, Uruguay.
For the last 60 years the CNS has characterized Salmonella
isolates of human, animal, food, feed, and environmental
origin, submitted voluntarily by several private and public
laboratories throughout the country. Furthermore, since
the beginning of the VETA program in 1995 (Vigilancia de
las Enfermedades Transmitidas por Alimentos — surveil-
lance of food-borne diseases) it has become mandatory
for samples from food-related outbreaks to be sent to
the CNS (http://www.bvsops.org.uy/pdf/veta00.pdf).17
The CNS also participates in the World Health Organization
global Salm-Surv program (http://www.who.int/salmsurv/
en/).6
Bacterial growth
Stock cultures stored in nutrient broth (8 g nutrient broth, 5 g
peptone, 3 g NaCl, 2 g/l Na2HPO412H2O) were isolated on
tryptic soy agar (TSA) (Difco, Detroit, MI, USA) and incubated
at 37 8C for 18—24 h.
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and 2 integrons underwent detection of Salmonella genomic
island 1 (SGI-1), phage typing, and pulsed-field gel electro-
phoresis (PFGE).
Bacterial phage typing
Phage typing of Salmonella Typhimurium was performed at
the National Reference Laboratory for Salmonella in Spain
with phages provided by the International Reference Labora-
tory (Colindale, London, UK), following international phage
typing methods.18
Antibiotic susceptibility testing
Antibiotic susceptibility testing was performed using the
standard disk diffusion (Kirby—Bauer) method, following
the Clinical and Laboratory Standards Institute (CLSI) recom-
mendations.19 The antibiotics tested included: ampicillin
(A), piperacillin (PIP), ampicillin/sulbactam (SAM), cepha-
lothin (KF), cefoxitin (FOX), cefuroxime (CXM), cefepime
(FEP), cefotaxime (CTX), ceftazidime (CAZ), imipenem
(IPM), gentamicin (G), amikacin (AK), kanamycin (K), tobra-
mycin (To), streptomycin (S), tetracycline (T), ciprofloxacin
(CIP), nalidixic acid (Nx), sulfafurazole (Su), trimethoprim
(Tm), trimethoprim/sulfamethoxazole (SXT), chlorampheni-
col (C), and nitrofurantoin (F). Escherichia coli ATCC 25922
and ATCC 35218 were used as reference strains.
For analysis of the results, intermediate and absolutely
resistant isolates were considered together as ‘resistant’.
Definitions of resistance patterns
To define different resistance patterns we took into consid-
eration the possible resistance mechanisms, hence resis-
tance to ampicillin and cephalothin, including cefuroxime
was considered as the same profile. Using the same criteria,
resistance to trimethoprim/sulfamethoxazole was not
included if isolates were resistant to both sulfafurazole
and trimethoprim.
PCR amplification
Detection of intI1 and intI2 genes was done employing spe-
cific primers, namely I3: GCGTTCGGTCAAGGTTCTGG and I5:
ACCGCCAACTTTCAGCACAT, and intI2-F: TTATTGCTGGGAT-
TAGGC and intI2-R: ACGGCTACCCTCTGTTATC, respectively.12
VR size was determined by PCR using 50CS and 30CS primers.20
PCR detection of SGI-1
Detection of SGI-1 was performed employing primers U7-L12/
LJR1 for the left junction and 104RJ/104D or C9L2/104D for
the right junction, as previously described in the literature.20
Pulsed-field gel electrophoresis
Only Salmonella isolates with intI1 and intI2 genes were
further characterized by PFGE in order to detect a possible
clonal dissemination of the resistances. PFGE was performedfollowing the PulseNet-Europe protocol (http://www.pulse
net-europe.org/docs.htm). Total DNAwas digested with XbaI
(Roche Applied Science, Madrid Spain), and the fragments
obtained were separated on 1% agarose (Seakem Gold Agar-
ose, Iberlabo, Spain) gels using the CHEF-DR-II system (Biorad
Laboratories Inc., Hercules, CA, USA). Electrophoresis was
carried out with 0.5 TBE buffer at 6 V/cm and 14 8C. The
running time was 21 h and the pulse ramp time was 2.2—
63.8 s. The XbaI-digested DNA from Salmonella Braenderup
H9812 was used as amolecular sizemarker. Pattern clustering
was performed using UPGMA (unweighted pair-group method
with an arithmetic mean) and the Dice coefficient with a
tolerance index of 0.5%. Fragments smaller than 30 kb were
disregarded according to the PulseNet guidelines for stan-
dardization.
Statistical analysis
To analyze the evolution of resistance, two time-periods were
established (1976—1988 and 1989—2000). Variableswere com-
pared using the Mantel—Haenszel Chi-square test for the
comparison of dichotomous variables and trend analysis using
SPSS 10.0 software package (SPSS, Chicago, IL, USA).
Results
Two hundred and fifty-eight Salmonella Typhimurium isolates
were recovered from the 283 archived isolates (91.2%). The
remaining 25 strains could not be recovered from storage
devices. One hundred and thirty-three isolates were from the
1976—1988 period and 125 isolates were from to 1989—2000
period.
Global resistance
All isolates were susceptible to amikacin, oxyiminocephalos-
porins, cephamycins, carbapenems, and fluoroquinolones.
However, only 78 isolates (30.2%) were susceptible to all
tested antibiotics. One hundred and one strains (39.1%)
presented resistance to a single antibiotic. Of these, 68
strains presented resistance to streptomycin, 16 to tetracy-
cline, 11 to sulfonamides, four to nitrofurantoin, one to
ampicillin, and one to nalidixic acid.
When analyzed individually, the highest levels of resis-
tance were to streptomycin (59.3%), followed by tetracycline
and sulfafurazole (25.6% and 22.1%, respectively). Results
are given in Table 1.
Overall, 38/258 strains (14.7%) were multi-resistant.
Twenty-eight different resistance patterns were identified
(see Table 2). Within this diversity the most frequently found
resistance pattern was AKSSuTmNxCToGTF (five isolates).
The second most frequently found pattern was ASSuTm,
which was found four times; however these isolates were
obtained in different years (1984, 1990, 1995, and 2000)
making the possibility of dissemination of a single strain
unlikely. The classic penta-resistant phenotype (ASSuCT),
usually conferred by the genomic island I (SGI-1),20 was
present in 12 isolates that also showed resistance to seven
or more antibiotics. In this context, we observed a high
frequency of co-resistance to Tm, K, and Nx (11/12), G
(9/12), F (8/12), and To (6/12) (see Table 2).
Table 1 Susceptibility rates of Salmonella Typhimurium iso-
lates (N = 258); Montevideo, 1976—2000.
Antibiotic Susceptible n (%) Resistant n (%)
Streptomycin 105 (40.7) 153 (59.3)
Tetracycline 192 (74.4) 66 (25.6)
Sulfafurazole 201 (77.9) 57 (22.1)
Ampicillin 212 (82.2) 46 (17.8)
Piperacillin 216 (83.7) 42 (16.3)
Ampicillin/sulbactam 219 (84.9) 39 (15.1)
Nalidixic acid 225 (87.2) 33 (12.8)
Cephalothin 223 (86.4) 35 (13.6)
Trimethoprim 226 (87.6) 32 (12.4)
Nitrofurantoin 231 (89.5) 27 (10.5)
Trimethoprim/
sulfamethoxazole
229 (88.8) 29 (11.2)
Kanamycin 230 (89.1) 28 (10.9)
Chloramphenicol 240 (93.0) 18 (7.0)
Gentamicin 242 (93.8) 16 (6.2)
Tobramycin 244 (94.6) 14 (5.4)
Cefuroxime 254 (98.4) 4 (1.6)
Amikacin 258 (100) 0.0
Cefepime 258 (100) 0.0
Cefotaxime 258 (100) 0.0
Cefoxitin 258 (100) 0.0
Ceftazidime 258 (100) 0.0
Ciprofloxacin 258 (100) 0.0
Imipenem 258 (100) 0.0
Table 2 Main features of the multi-resistant strains.
Resistance profilea n Isolates and integronsb,c, d
AKSNx 1 (048/77)intI2
ASSuT 2 (074/77)intI2, (03/92)
ASTmSxt 1 (016/84)intI2
ASNxF 1 (079/77)
SSuToT 1 (018/94)
ASSuTm 4 (015/84,027/90,004/95)
(178/00).intI1
AKSToG 1 (047/81)
AKSSuNx 1 (076/77) intI2
ASSuTmNx 1 (058/77) intI2
AKSSuTm 1 (030/91)
ASTmNxTF 1 (090/78) intI2
AKSSuTmNx 1 (096/78) intI2
ASSuTmCT 1 (222/00)
AKSSuNxCT 1 (059/77) intI1
AKSTmNxTF 1 (098/78) intI2
AKSTmNxGF 1 (071/77) intI2
ASSuTmNxCF 1 (092/78) intI2
ASSuTmNxGT 1 (020/81) intI2
AKSSuTmNxT 1 (021/81) intI2
AKSSuTmNxTF 1 (130/78) intI2
KSSuNxCToGT 1 (157/79) intI1
AKSSuTmNxCToG 2 (165/793, 102/783)
intI1 intI2
AKSSuTmNxCTF 1 (024/812)
intI1 intI2
AKSSuTmNxCGT 1 (068/772)
intI1 intI2
AKSSuTmNxCToGF 1 (100/783)
intI1 intI2
AKSSuTmNxCToGT 1 (164/793)
intI1 intI2
AKSSuTmNxCGTF 2 (091/78,009/81) intI2
AKSSuTmNxCToGTF 5 (094/783,101/783,116/781,
154/793,058/830)
intI1 intI2
S, streptomycin; T, tetracycline; Su, sulfafurazole; A, ampicillin; Nx,
nalidixic acid; Tm, trimethoprim; F, nitrofurantoin; Sxt, trimetho-
prim/sulfamethoxazole; K, kanamycin; C, chloramphenicol; G, gen-
tamicin; To, tobramycin.
a Bold letters indicate the penta-resistance profile.
b The presence of class-1 (intI1) and/or 2 (intI2) integrons is shown
in superscript; () no integrons detected.
c The profile of the variable region size using 50CS—30CS primers is
shown in subscript; 0: no band, 1: one band (1000 bp), 2: two bands
(900—1100 bp), 3: three bands (900, 1100, 3000 bp).
d The number after the slash (/) indicates the year of isolation.
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of the 1970s or early 1980s. All of these isolates were
obtained before the description of SGI-1-bearing Salmonella
Typhimurium.
Detection of class 1 integrons, class 2 integrons,
and their variable regions
We searched for the occurrence of integrons in the multi-
resistant Salmonella Typhimurium isolates. Twenty-nine out
of 38 strains presented integrons: three isolates had only
class 1 integrons, 15 isolates showed only class 2 integrons,
and 11 isolates presented both.
The presence of these genetic elements was related to the
number of different antibiotics to which the strains displayed
resistance. In this sense, strains that were resistant to four to
six different drugs presented no integrons or only one class of
integrons (mainly class 2). When strains showed resistance to
seven different drugs, at least one type of integrons could be
detected (mainly class 2). The presence of both classes of this
genetic element was common in those strains that showed
resistance to at least nine different antibiotics. All isolates
belonging to the most frequent phenotype (AKSSuTmNxC-
ToGTF) harbored both classes of integrons, while most iso-
lates (3/4) belonging to the second most frequent (ASSuTm)
had none.
Isolates harboring class 1 and 2 integrons were found to be
carrying VRs of four different sizes, namely 900, 1000, 1100,
and 3000 bp. According to the presence/absence of these
VRs, we designated four profiles: 0 (no band), 1 (one band;
1000 bp), 2 (two bands; 900—1100 bp), and 3 (three bands;900, 1100, and 3000 bp) (see Table 2). Although some of the
VRs showed sizes similar to those present in SGI-1,20 PCR
assays using primers U7-L12/LJR1 and 104RJ/104D or C9L2/
104D were negative, ruling out the occurrence of SGI-1
(regardless of the variant) in these isolates.
Phage typing and PFGE
Eleven multi-resistant Salmonella Typhimurium isolates
(intI1 and intI2 positive) were characterized by phage typing
and PFGE. Three belonged to phage-type DT193, one to
DT194, and one to DT195; the remaining six were non-type-
able (Figure 1).
Five of these strains displayed the same antibiotic resis-
tance profile, AKSSuTmNxCToGTF (strains 154/79, 58/83,
101/78, 116/78, 94/78). Even though four of these isolates
Figure 1 Phylogenetic tree of the 11 multi-resistant Salmonella Typhimurium isolates harboring class 1 and 2 integrons included in
the pulsed-field gel electrophoresis assay. Along with the restriction pattern obtained for each strain is the information regarding its
serotype and phage type. The tree was obtained by the UPGMAmethod (unweighted pair-groupmethod with an arithmetic mean) using
a 0.5% Dice coefficient and 1.5% tolerance.
Table 3 Resistance comparison for the two time periods.
Antibiotic Period
1976—1988
(n = 133)
n (%)
1989—2000
(n = 125)
n (%)
p-Valuea
Ampicillin 37 (27.8%) 9 (7.2%) <0.001
Ampicillin/sulbactam 34 (25.6%) 5 (4%) <0.001
Piperacillin 34 (25.6%) 8 (6.4%) <0.001
Cephalothin 29 (21.8%) 6 (4.8%) <0.001
Gentamicin 16 (12.0%) 0 (0%) <0.001
Kanamycin 26 (19.5%) 2 (1.6%) <0.001
Streptomycin 84 (63.2%) 71 (56.8%) 0.359
Tobramycin 13 (9.8%) 1 (0.8%) 0.001
Sulfafurazole 43 (32.3%) 14 (11.2%) <0.001
Trimethoprim 25 (18.8%) 7 (5.6%) 0.001
Trimethoprim/
sulfamethoxazole
24 (18.0%) 5 (4%) <0.001
Chloramphenicol 17 (12.8%) 1 (0.8%) <0.001
Tetracycline 49 (36.8%) 17 (13.6%) <0.001
Nalidixic acid 30 (22.6%) 3 (2.4%) <0.001
Nitrofurantoin 22 (16.5%) 5 (4%) 0.002
a Statistical significance of the difference in antibiotic resistance
between the two time periods.
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phage types as well as different restriction patterns, ruling
out the possibility of a single strain circulating in the popula-
tion.
Another two isolates displayed similar antibiotic resis-
tance profiles, namely strains 102/78 and 165/79 (AKS-
SuTmNxCToG), yet their restriction patterns were different
as well as their phage-type (Figure 1).
Although types DT193, DT194, and DT195 are not among
the most frequently found in our region, DT193 has been
detected in human isolates from Brazil.21 Interestingly, type
DT195 is the main phage-type recovered from pork products
in the southern-most part of Brazil.22
Antibiotic resistance evolution in Salmonella
Typhimurium
Comparison of antibiotic resistance levels between the two
time periods (1976—1988 and 1989—2000) shows a statistically
significant decrease in resistance to almost every antibiotic
between the years 1989—2000, except for streptomycin, to
which resistance remained constant, as reflected in the highp-
value (Table 3). Accordingly, a larger numberofmulti-resistant
isolates were recovered for the earlier period (31 isolates
versus seven isolates during the period 1989—2000).
Discussion
When compared to European antibiotic resistance levels, our
findings show that during the years 1989—2000 streptomycin
resistance was 56.8%, similar to values reported in Spain
(61%)7,23 and slightly lower than those reported in France
(71%).24 We also found similar low values (i.e., <5%) of
resistance to gentamicin, kanamycin, and nalidixic acid
(Table 3). However, we did find considerable differences
between our country and European countries in antibioticresistance levels to ampicillin (7.2% vs. 65%), sulfafurazole
(11.2% vs. 70%), chloramphenicol (0.8% vs. 58%), and tetra-
cycline (13.6% vs. 80%).7,23—25 The SENTRY surveillance pro-
gram, which includes other South American countries, has
reported similar levels of resistance to ampicillin and tetra-
cycline, but higher levels for other antibiotics such as nali-
dixic acid and trimethoprim/sulfamethoxazole.4,25
International guidelines recommend the use of oxyimino-
cephalosporins and fluoroquinolones to treat serious or inva-
sive Salmonella infections. In this regard, we did not find any
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the surveillance period.
Resistance to fluoroquinolones generally occurs by small
stepwise increases in its minimum inhibitory concentration,
and in most cases it first involves resistance to non-fluori-
nated quinolones such as nalidixic acid.26 Bearing this in
mind, the low number of quinolone-resistant strains isolated
in this study (2.4%) somehowminimizes the probability of the
occurrence of resistance to newer quinolones. Moreover, we
did not find resistance to amikacin, which could lead us into
thinking about the potential participation of a recently
described variant of an aminoglycoside-acetylating enzyme,
namely Aac(60)-Ib-cr.27 This enzyme has already been
detected in our country.28 However, surveillance programs
aimed at detecting resistance to such antibiotics are neces-
sary due to the continuous detection of new transferable
quinolone resistance mechanisms.
The decrease in antibiotic resistance witnessed during the
second time period (i.e., the years 1989—2000) goes hand in
hand with a decrease in the occurrence of integrons in these
strains isolated over the same time-span. Just one isolate
from this period presented these elements (class 1). We have
not found a clear explanation for this notable decrease in
antibiotic resistance between the two periods, since Salmo-
nella infections are only treated with antibiotics in serious
cases, and therefore they are rarely exposed to this kind of
selective pressure. On the other hand, the continuous strep-
tomycin resistance is not related to human usage, since this
antibiotic has fallen out of use in medicine in our country.
Different hypotheses have been proposed, one of which is
related to the availability of drinking water and good water
treatment facilities in our country (so far Uruguay is the only
country in South America free from cholera); this rules out
the possibility of infection from this source.
Even though livestock production in Uruguay is extensive,
antimicrobials are not frequently used for growth promotion
since the production system is mostly based on grazing. In
recent years, the National Program of Biological Wastes did
not find antibiotic traces in cattle (Mendez R, personal
report). Infection from other animal sources, through the
food chain, is low due to the low level of poultry and pork
production in the country . In this context, we have recently
found that the genotypes of Salmonella Enteritidis involved
in human infection derive mainly from poultry and eggs,29
which suggest that this constitutes the main source of trans-
mission to humans. The introduction almost 20 years ago of a
live, attenuated Salmonella vaccine aimed at protecting
poultry against infection by Salmonella serovar Gallinarum,
probably resulted in an important decrease in antibiotic
administration to fowl birds. The removal of this selective
pressure could have favored the colonization of the avian gut
by antibiotic-susceptible strains, therefore partially explain-
ing the decrease in the recovery of resistant isolates from
humans.
Two issues should be kept in mind while analyzing the
results obtained. Firstly, although this is a retrospective
analysis and some isolates may have lost their antibiotic-
resistance during storage or during recovery, it would be
reasonable to think that this would be the case for those
strains stored for longer periods; yet these strains are the
ones with the highest levels of antibiotic-resistance. Sec-
ondly, this report represents the evolution of antibiotic-resistance of every Salmonella Typhimurium isolate sub-
mitted to the CNS; however, it should be taken into account
that the study of food-related outbreaks prior to 1995 was
not mandatory, and that the study of isolated cases is also
not mandatory. In this sense those strains obtained during
the second time period can be seen as being more repre-
sentative of our reality than those isolated during the first
time period. If we consider only those isolates obtained
from 1995 to 2000 (75 out of 125 strains obtained through-
out the second time period), only three of them (004/95,
178/00, and 222/00) were multi-resistant (see Table 2).
These results clearly reflect the marked reduction in anti-
biotic resistance levels of the Salmonella Typhimurium
strains isolated in Uruguay during recent years.
These results are similar to those observed with other
enterobacteria in our country, such as EPEC, where resis-
tance levels have fallen during the past 15 years.30
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